Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
24,303,337
-
Share change
-
+98,217
-
Total reported value
-
$335,549,678
-
Put/Call ratio
-
30%
-
Price per share
-
$13.81
-
Number of holders
-
137
-
Value change
-
-$206,134
-
Number of buys
-
53
-
Number of sells
-
72
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q2 2022
As of 30 Jun 2022 INTERCEPT PHARMACEUTICALS IN - COM (ICPT) had 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 24,303,337 shares of stock of the company.
Largest 10 holders included STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, MACQUARIE GROUP LTD, Samsara BioCapital, LLC, and Rockefeller Capital Management L.P..
This table shows 137 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.